文献速递神经儿科影像MR

扩散加权成像鉴别BRAF V600E突变型与野生型大脑毛细胞型星形细胞瘤和神经节胶质瘤的作用

Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
PubMed 文献 · Neuroradiology · 2019-10-30

这项回顾性多中心研究纳入56例初治儿童毛细胞型星形细胞瘤和神经节胶质瘤,分析BRAF V600E突变型与野生型的影像特征,聚焦DWI。突变型肿瘤rADCmean和rADCmin显著低于野生型(均p<0.001),rADCmin预测BRAF V600E状态的AUC为0.885,rADCmean为0.831。除突变型毛细胞型星形细胞瘤囊性成分数量显著更多(p=0.011)外,其他影像特征无显著差异。

要点

  • BRAF V600E突变型毛细胞型星形细胞瘤和神经节胶质瘤的rADCmean和rADCmin均显著低于野生型(p<0.001)。
  • rADCmin预测BRAF V600E状态的AUC为0.885,rADCmean为0.831,两者判别效能相近。
  • 突变型毛细胞型星形细胞瘤中伴囊性成分的肿瘤数量显著多于野生型(p=0.011)。

关键影像表现/征象

  • BRAF V600E突变型毛细胞型星形细胞瘤和神经节胶质瘤的rADCmean和rADCmin均显著低于野生型(均p<0.001),不受肿瘤组织学类型和部位影响。
  • 除突变型毛细胞型星形细胞瘤中伴囊性成分的肿瘤数量显著更多(p=0.011)外,突变型与野生型在其他影像特征上无显著差异。

诊断标准与关键数值

  • rADCmean预测BRAF V600E状态:AUC 0.831,p<0.001。
  • rADCmin预测BRAF V600E状态:AUC 0.885,p<0.001。

临床应用与阅片要点

  • 在儿童毛细胞型星形细胞瘤和神经节胶质瘤的MRI评估中,可关注DWI的rADCmean和rADCmin以辅助预测BRAF V600E状态。
  • 突变型毛细胞型星形细胞瘤中伴囊性成分的肿瘤数量显著更多(p=0.011),可作为辅助线索。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: BRAF V600E mutation is a distinctive genomic alteration of pediatric low-grade gliomas with prognostic and therapeutic implications. The aim of this retrospective multicenter study was to analyze imaging features of BRAF V600E-mutant and wild-type cerebral pilocytic astrocytomas (PAs) and gangliogliomas (GGs), focusing on the role of diffusion weighted imaging (DWI).

METHODS: We retrospectively evaluated 56 pediatric patients with histologically proven, treatment-naïve PAs and GGs who underwent conventional MRI, DWI, and molecular analysis for BRAF V600E mutation. Twenty-three subjects presented BRAF V600E-mutant (12 PAs and 11 GGs) and 33 BRAF V600E wild-type (26 PAs and 7 GGs) tumors. Imaging studies were reviewed for dominant site, margin definition, hemorrhage, calcification, cystic components, contrast enhancement, and relative mean and minimum ADC values (rADCmean and rADCmin). Statistics included Fisher's exact test, Student t test, general linear model, and receiver operating characteristic (ROC) analysis.

RESULTS: PA and GG BRAF V600E-mutant had significantly lower rADCmean (p < 0.001) and rADCmin (p < 0.001) values than wild type, regardless of tumor histology and location. ROC analysis demonstrated similar performances between these parameters in predicting BRAF V600E status (rADCmean: AUC 0.831, p < 0.001; rADCmin: AUC 0.885, p < 0.001). No significant differences regarding additional imaging features emerged between BRAF V600E-mutant and wild-type lesions, with the exception of the number of tumors with cystic components, significantly higher in BRAF V600E-mutant PAs (p = 0.011) CONCLUSION: Assessment of the DWI characteristics of GGs and PAs may assist in predicting BRAF V600E status, suggesting a radiogenomic correlation and prompt molecular characterization of these tumors.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Ramaglia A, Tortora D, Mankad K, et al. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type. Neuroradiology. 2019. PMID: 31667545. doi:10.1007/s00234-019-02304-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。